Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 175

    1.

    The relationship between cancer and rheumatoid arthritis: still a large research agenda.

    Love T, Solomon DH.

    Arthritis Res Ther. 2008;10(3):109. Epub 2008 May 14.

    PMID:
    18495048
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Malignancy and rheumatoid arthritis.

    Askling J.

    Curr Rheumatol Rep. 2007 Oct;9(5):421-6. Review.

    PMID:
    17915099
    [PubMed - indexed for MEDLINE]
    3.

    Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.

    Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, Cook EF, Carney G, Schneeweiss S.

    Arthritis Rheum. 2006 Sep;54(9):2757-64. Erratum in: Arthritis Rheum. 2006 Oct;54(10):3134.

    PMID:
    16947774
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Rheumatoid arthritis and malignant lymphomas.

    Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L.

    Curr Opin Rheumatol. 2004 May;16(3):254-61. Review.

    PMID:
    15103253
    [PubMed - indexed for MEDLINE]
    5.

    Rheumatologists, take heart! We may be doing something right.

    van Vollenhoven RF.

    Arthritis Res Ther. 2008;10(2):105. Epub 2008 Mar 7.

    PMID:
    18341711
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Associations between rheumatoid arthritis and malignancy.

    Chakravarty EF, Genovese MC.

    Rheum Dis Clin North Am. 2004 May;30(2):271-84, vi. Review.

    PMID:
    15172040
    [PubMed - indexed for MEDLINE]
    7.

    Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy?

    Brar A, Hiebert T, El-Gabalawy H.

    Nat Clin Pract Rheumatol. 2007 Mar;3(3):120-1. No abstract available.

    PMID:
    17334334
    [PubMed - indexed for MEDLINE]
    8.

    High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis.

    Goldstein RS.

    Arthritis Res Ther. 2008;10(3):111. Epub 2008 Jun 2.

    PMID:
    18557992
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Tumour necrosis factor blockade and the risk of osteoporosis: back to the future.

    Sambrook P.

    Arthritis Res Ther. 2007;9(4):107.

    PMID:
    17850677
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

    Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU; GO-AFTER study investigators.

    Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26. Erratum in: Lancet. 2009 Oct 24;374(9699):1422.

    PMID:
    19560810
    [PubMed - indexed for MEDLINE]
    11.

    Association of infections and tuberculosis with antitumor necrosis factor alpha therapy.

    Patkar NM, Teng GG, Curtis JR, Saag KG.

    Curr Opin Rheumatol. 2008 May;20(3):320-6. Review.

    PMID:
    18388525
    [PubMed - indexed for MEDLINE]
    12.

    Comparative overview of safety of the biologics in rheumatoid arthritis.

    Khraishi M.

    J Rheumatol Suppl. 2009 Jun;82:25-32. Review.

    PMID:
    19509327
    [PubMed - indexed for MEDLINE]
    13.

    Rheumatoid arthritis and tuberculosis in the tumor necrosis factor inhibitors era: observations from Brazil.

    da Rocha Castelar Pinheiro G.

    J Clin Rheumatol. 2005 Dec;11(6):344-6. No abstract available.

    PMID:
    16371812
    [PubMed - indexed for MEDLINE]
    14.

    Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.

    Ferri C, Ferraccioli G, Ferrari D, Galeazzi M, Lapadula G, Montecucco C, Triolo G, Valentini G, Valesini G; GISEA Group.

    J Rheumatol. 2008 Oct;35(10):1944-9. Epub 2008 Aug 1.

    PMID:
    18688917
    [PubMed - indexed for MEDLINE]
    15.

    The incidence of cancer associated with the treatment of rheumatoid arthritis.

    Beauparlant P, Papp K, Haraoui B.

    Semin Arthritis Rheum. 1999 Dec;29(3):148-58.

    PMID:
    10622679
    [PubMed - indexed for MEDLINE]
    16.

    [Link between rheumatoid arthritis and cancer].

    Whelan P.

    Z Rheumatol. 2006 Oct;65(6):497-8, 500-2, 504. Review. German.

    PMID:
    17004050
    [PubMed - indexed for MEDLINE]
    17.

    Rheumatoid arthritis in dermatology.

    Hata T, Kavanaugh A.

    Clin Dermatol. 2006 Sep-Oct;24(5):430-7. Review.

    PMID:
    16966022
    [PubMed - indexed for MEDLINE]
    18.

    Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.

    Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A.

    JAMA. 2009 Feb 18;301(7):737-44.

    PMID:
    19224750
    [PubMed - indexed for MEDLINE]
    19.

    Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.

    Segal B, Rhodus NL, Patel K.

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Dec;106(6):778-87. Epub 2008 Oct 19. Review.

    PMID:
    18930662
    [PubMed - indexed for MEDLINE]
    20.

    Antitumor necrosis factor-alpha therapy and potential cancer inhibition.

    Williams GM.

    Eur J Cancer Prev. 2008 Apr;17(2):169-77. Review.

    PMID:
    18287875
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk